Healthcare’s Elder Statesmen

  • With major contributions to healthcare for nearly 120 years, BD’s products are staples of every hospital, clinic, and doctor’s office.
  • Can its stock price and profits continue to advance in today’s healthcare environment?
  • Has it managed its maturing product suite and invested well for future growth?
  • How will its acquisition of C.R. Bard affect BD’s financial health?